What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

This research investigates the effectiveness of polyamine blockade in treating gliomas, particularly focusing on DFMO.

November 1, 2025Neuro-OncologyOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Evaluating DFMO's effect on immune responses in glioma models highlights its potential as a therapeutic target.

This research investigates the effectiveness of polyamine blockade in treating gliomas, particularly focusing on DFMO.
Utilized murine glioma model and patient-derived xenograft (PDX) cell lines.
Compared CT-2A variants: one responsive to immunotherapy and one resistant to PD-1 blockade.
Conducted in vitro and in vivo experiments to assess the efficacy of DFMO.
DFMO did not improve survival in immunotherapy-sensitive CT-2A, but extended survival by 8 days in immunotherapy-resistant tumors.
Transcriptomic analysis indicated lower expression of immune-related genes in DFMO-responsive tumors.
Findings suggest polyamine-targeted therapy may benefit gliomas with an immunosuppressive phenotype.

SUZUKI et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark